(firstQuint)Dose-finding Pharmacokinetic Study in Healthy Males.

 This is a phase I, open, repeated dose, randomised PK study in healthy males.

 The study will consist of 4 parallel groups (Groups 1-4).

 All groups will have a crossover design with 4 treatment periods, each lasting for 7 days.

.

 Dose-finding Pharmacokinetic Study in Healthy Males@highlight

This is a phase I PK study in healthy males.

